Clindamycin phosphate vaginal cream 2%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Clindamycin phosphate vaginal cream 2%, covering 2019-12-26 to 2019-12-26. Get the full timeline:
Most recent: Clinical Trial Update: A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant Women [Phase 3]